Inventor
TZITZILONIS CHRISTOS
US14 patents
⚠️ This page may combine multiple inventors who share the name “TZITZILONIS CHRISTOS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ROCHE SEQUENCING SOLUTIONS INC
9 patentsUS11767348B2Sep 26, 2023
OmpG variants
ROCHE SEQUENCING SOLUTIONS INC4 citations83
US10752658B2Aug 25, 2020
OmpG variants
ROCHE SEQUENCING SOLUTIONS INC7 citations81
US10752948B2Aug 25, 2020
Alpha-hemolysin variants
ROCHE SEQUENCING SOLUTIONS INC5 citations79
US11001611B2May 11, 2021
Site-specific bio-conjugation methods and compositions useful for nanopore systems
ROCHE SEQUENCING SOLUTIONS INC2 citations72
US12037366B2Jul 16, 2024
OMPG variants
ROCHE SEQUENCING SOLUTIONS INC2 citations70
US11261488B2Mar 1, 2022
Alpha-hemolysin variants
ROCHE SEQUENCING SOLUTIONS INC1 citations68
US12479893B2Nov 25, 2025
Site-specific bio-conjugation methods and compositions useful for nanopore systems
ROCHE SEQUENCING SOLUTIONS INC0 citations62
US11866464B2Jan 9, 2024
Site-specific bio-conjugation methods and compositions useful for nanopore systems
ROCHE SEQUENCING SOLUTIONS INC0 citations62
US12435114B2Oct 7, 2025
OmpG variants
ROCHE SEQUENCING SOLUTIONS INC0 citations59
REVOLUTION MEDICINES INC
4 patentsUS11702411B2Jul 18, 2023
Pyridine, pyrazine, and triazine compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations60
US12365688B2Jul 22, 2025
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations59
US11739093B2Aug 29, 2023
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC1 citations59
US11673901B2Jun 13, 2023
Polycyclic compounds as allosteric SHP2 inhibitors
REVOLUTION MEDICINES INC0 citations47